ADC Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $18,839 | $23,033 | $16,910 | $18,464 |
Gross Profit | 18,003 | 20,972 | 15,539 | 17,613 |
EBITDA | -41,555 | -28,464 | -18,832 | -29,700 |
EBIT | -42,395 | -29,265 | -19,625 | -30,502 |
Net Income | -56,646 | -38,602 | -30,727 | -43,969 |
Net Change In Cash | 18,839 | 23,033 | 16,910 | 18,464 |
Free Cash Flow | -24,087 | -56,598 | -21,942 | -25,259 |
Cash | 264,560 | 194,701 | 250,867 | 274,272 |
Basic Shares | 113,743 | 107,202 | 105,396 | 104,824 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $70,837 | $69,558 | $209,908 | $33,917 |
Gross Profit | 64,888 | 67,029 | 205,329 | 32,524 |
EBITDA | -103,712 | -146,762 | -108,055 | -223,715 |
EBIT | -106,988 | -150,029 | -110,443 | -226,345 |
Net Income | -157,846 | -240,053 | -155,800 | -230,026 |
Net Change In Cash | 70,837 | 69,558 | 209,908 | 33,917 |
Free Cash Flow | -124,702 | -121,902 | -139,092 | -239,754 |
Cash | 250,867 | 278,598 | 326,441 | 466,544 |
Basic Shares | 97,159 | 81,712 | 78,152 | 76,748 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.25 |
2025-03-31 | -$0.36 |
2024-12-31 | -$0.25 |
